3 Major Moves Positioning Google Sister Company, Verily, to Reckon with Traditional Clinical Laboratories
Now an FDA EUA for Verily’s SARS-CoV-2 pooled testing that can test 12 samples at once—Google sister company’s clinical laboratory test leanings continue entry into market.
Three essential points pertaining to university laboratories planning for SARS-CoV-2 surveillance testing.
Mayo Clinic Director of Clinical Virology Matthew J. Binnicker, PhD, explains when clinical laboratories should consider pooled testing for SARS-CoV-2.
To clear up any ambiguity, the EUA further clarifies that only one testing option is permitted under the initial EUA.
If the COVID-19 pandemic continues into 2021, then clinical laboratories can expect many new competitors for SARS-CoV-2 testing.
Guidance released Sept. 8 provides simplified details on nursing home testing that should be performed, also identifies three circumstances related to COVID-19 testing triggers.
Abbott SARS-CoV-2 Antigen Test Receives EUA, Had $760 Million Deal Pending With Federal Government in Less Than 48 Hours
Federal collaboration with Abbott materializes into contract quickly after BinaxNOW COVID-19 Ag Card EUA announcement.
Four key points from the FDA’s September 2020 update to initial COVID-19 convalescent plasma guidelines.
Laboratory Expert Identifies Viral Load and Co-infections as Commonly Overlooked Tests for COVID-19 Patients
Pathologist Frederick (Fritz) Kiechle, MD, PhD, reviews two potential testing strategies associated with COVID-19 management.
CDC Updates SARS-CoV-2 Testing Guidelines, Reducing Recommendations for Testing Those Who Have Been Exposed
With another change to CDC COVID-19 testing guidance, clinical laboratories may begin to see more fluctuations in test volumes because of potentially conflicting federal, state, and local testing guidance.